The drugs include Novo Nordisk’s Wegovy and Ozempic as well as Eli Lilly’s Zepbound and Mounjaro. In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an ...
Novo Nordisk A/S’s appetite-blocking shot semaglutide, sold under the brand names Ozempic and Wegovy, will probably become the world’s top-selling drug franchise next year. It broke open a ...
GLP-1 drugs like Ozempic, Mounjaro, and Trulicity were first approved by the FDA for treating Type 2 diabetes. But many Americans are seeking these medications for weight loss, while navigating ...